Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
japan society for the promotion of science (20K08633, 21K16189, 21K17278)
- License Information
-
More Information
Article History
Received: 26 June 2021
Accepted: 24 October 2021
First Online: 8 November 2021
Declarations
:
: HY has received research grants from Daiichi-Sankyo Company, Mitsubishi Tanabe Pharma Corporation and Baxter, and lecture fees from Mitsubishi Tanabe Pharma Corporation and AstraZeneca. MY has received grants from Astellas Pharma Inc., Kyowa Kirin Corporation, Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical Corporation and Baxter, and research funding from Mitsubishi Tanabe Pharma Corporation, Boeringer Ingelheim Japan, and Boeringer Ingelheim Germany, and lecture fees from Chugai Pharmaceutical Corporation, Kyowa Kirin Corporation, and Mitsubishi Tanabe Pharma Corporation.
: All animal handling and experimentation was conducted in accordance with the guidelines and with approval of the Animal Experimentation Committee of Kyoto University (MedKyo 20186).
